Keywords: peregrine, deal, niaid, anglo-swedish, drug, major, astrazeneca

Peregrine in R&D deal with NIAID

Article | 25 June 2007

Print This

Anglo-Swedish drug major AstraZeneca says that, following a comprehensive analysis of pre- and post-marketing data by the UK's Medicines and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in